Aurinia Named Company of the Year by LifeSciences BC
February 20 2018 - 3:01PM
Business Wire
Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) today
announced it has received this year’s Company of the Year Award
from LifeSciences BC. The 2018 LifeSciences BC award winners will
be recognized at this year’s annual dinner presented by FARRIS,
held on April 19, 2018 in Vancouver.
“As a company that has its roots in British Columbia, we are
thrilled to accept this award,” said Richard M. Glickman, Chairman
and CEO of Aurinia. “I am proud of Aurinia’s progress over the last
year and our ability to contribute to the advancement of the life
sciences in our native British Columbia. Our drive to succeed is
fueled by patients and their families, who continue to inspire us
as we work to make innovative therapies available as quickly and
efficiently as possible.”
About AuriniaAurinia is a clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are suffering
from serious diseases with a high unmet medical need. The company
is currently developing an investigational drug, for the treatment
of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS),
minimal change disease MCD and dry eye syndrome (DES). The company
is headquartered in Victoria, BC and focuses its development
efforts globally. For further information, see our website at
www.auriniapharma.com.
About LifeSciences BCLifeSciences BC is a not-for-profit,
non-government, industry association that supports and represents
the life sciences community of British Columbia through leadership,
facilitation of investment and partnering, advocacy, and promotion
of our world-class science and industry. Life sciences sectors,
from biopharmaceuticals and medical technology, to digital health
and medical devices, are integrated into our organization and all
that we do, ensuring that no life sciences sector is working in
isolation — and that all sectors come together in a comprehensive,
complementary and coordinated fashion. Throughout the year,
LifeSciences BC undertakes numerous programs and projects in
support of these sectors. These include public policy initiatives,
facilitating linkages between global industry and our local
organizations, raising the profile of our industry internationally
and thus facilitating investment and global partnering
opportunities, and helping nurture economic development in British
Columbia through the life sciences industry.
We seek safe harbor.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180220006518/en/
Aurinia Pharmaceuticals Inc.Investor Contact:Celia
EconomidesVP, Corporate & Public
AffairsIR@auriniapharma.comorMedia:Christopher Hippolyte,
212-364-0458Christopher.hippolyte@inventivhealth.com